Skip to main content

Month: June 2023

Emerging Markets Report: In Pursuit of a Tipping Point

An Emerging Markets Sponsored Commentary ORLANDO, Fla., June 20, 2023 (GLOBE NEWSWIRE) — Anonymous Intelligence Company Inc. (CSE: ANON) (OTC: ANICF) (FRANKFURT: 1JI0)  is a leading, computational intelligence, decentralized network and data technology company, focused on leveraging its proprietary suite of AI & privacy enabled products to empower increased confidence in technology for consumers and business alike. Simply put, Anonymous Intelligence Company is pioneering a new era where robust AI platforms and assured privacy come together to empower and simplify your future. See the Company’s Investor Presentation here. Here are a few recent headlines from the Company: Anonymous Intelligence Company announces “Turminal.ai” a revolutionary privacy protected AI dashboard Anonymous Intelligence Company Signs LOI to Acquire Enterprise...

Continue reading

Helius Medical Technologies Announces DMEPOS Accreditation for PoNS

— Critical initial step toward US reimbursement — NEWTOWN, Pa., June 20, 2023 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that its Portable Neuromodulation Stimulator (PoNS®) device has been awarded Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) accreditation by The Compliance Team (TCT), which is authorized by the Centers for Medicare & Medicaid Services (CMS) to accredit all DMEPOS products and services. The accreditation certifies that Helius has established processes that conform to TCT’s Exemplary Provider® DMEPOS Quality Standards. “We are thrilled that PoNS has been awarded DMEPOS accreditation. Not...

Continue reading

uniQure announces achievement of $100 million milestone related to hemophilia B gene therapy

Milestone payment triggered by first commercial sale of HEMGENIX® in U.S. by CSL Behring LEXINGTON, Mass. and AMSTERDAM, June 20, 2023 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, announced the achievement of a $100 million milestone associated with the first commercial sale of HEMGENIX® in the United States by its partner, global biotechnology leader CSL (ASX: CSL). HEMGENIX® (etranacogene dezaparvovec) is a one-time administered gene therapy for the treatment of adults with hemophilia B who currently use factor IX prophylaxis therapy, or have current or historical life-threatening hemorrhage or have repeated, serious spontaneous bleeding episodes. “The first commercial sale in the U.S. is a major milestone for uniQure...

Continue reading

The Joint Corp. Acquires Wisconsin Regional Developer Territory Rights

Enhances Profitability Profile SCOTTSDALE, Ariz., June 20, 2023 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care through The Joint Chiropractic® network, acquired the regional developer (RD) territory rights for Wisconsin for $950,000 on June 15, 2023. The demographic modeling for Wisconsin indicates the potential for a total of 53 clinics, including the 21 existing franchised clinics, one clinic in active development and 31 sites for future clinic development. “Acquiring the regional developer territory rights for Wisconsin will increase the margin contribution within the franchise segment,” said President and Chief Executive Officer of The Joint Corp. Peter D. Holt. “As the composition of our franchise system evolves, we continually evaluate opportunities, balancing increased...

Continue reading

Chindata Group Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

BEIJING, June 20, 2023 (GLOBE NEWSWIRE) — Chindata Group Holdings Limited (“Chindata Group” or the “Company”) (Nasdaq: CD), a leading carrier-neutral hyperscale data center solution provider in Asia-Pacific emerging markets, today announced that the special committee (the “Special Committee”) of the Company’s board of directors (the “Board”), formed to evaluate and consider the previously announced preliminary non-binding acquisition proposal letter dated June 6, 2023 (the “Proposal”), has retained Citigroup Global Markets Asia Limited as its independent financial advisor and Gibson, Dunn & Crutcher as its U.S. legal counsel to assist it in this process. The Company cautions its shareholders and others considering trading in its securities that neither the Board nor the Special Committee has made any decision with respect...

Continue reading

TC Energy’s strategic alignment of 2023 priorities and energy transition, showcased at Sustainable Energy Forum

Over 60 per cent of secured capital projects directly enable global climate goals CALGARY, Alberta, June 20, 2023 (GLOBE NEWSWIRE) — News Release — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) is hosting a Sustainable Energy Forum today to highlight the Company’s role in enabling the energy transition while delivering long-term shareholder value. Today’s event includes presentations from TC Energy President and CEO François Poirier, Bruce Power President and CEO Mike Rencheck, and senior leaders at the forefront of the Company’s sustainable energy strategy. TC Energy’s highly integrated North American asset base is enabling the energy transition and supporting the path to net zero by 2050. More than 60 per cent of its $34 billion total secured capital program is directly funding solutions to support global...

Continue reading

Graphex Group Retains Maxim Group to Explore U.S. Spinoff of its Graphex Technologies Business

The international technology company moves to accelerate its growth strategy to domesticate North American graphite supply via a standalone U.S. company. ROYAL OAK, Mich., June 20, 2023 (GLOBE NEWSWIRE) — Graphex Group Limited, together with its wholly owned US subsidiary, Graphex Technologies, LLC (“Graphex” or the “Company”) (NYSE American: GRFX | HKSE: 6128), a multinational technology company focused on the development of technologies and products to enhance renewable energy, is pleased to announce that it has engaged the services of New York City-based investment bank and financial advisory firm, Maxim Group LLC (“Maxim”). Maxim will provide financial advisory services in relation to the potential spinoff of Graphex Technologies, LLC. The terms and conditions of any spinoff will be determined after analysis by...

Continue reading

GCC Steam Condensate Piping Market Driven by Growing Industrialization and Demand for Energy Efficiency

According to SkyQuest, the increase in manufacturing and processing industries has increased demand for steam infrastructure, including condensate steam piping. The drained steam condensate retains a significant amount of heat energy that can be reused by other processes that require less heat. However, steam condensate piping requires frequent maintenance and can be relatively costly. Westford, USA, June 20, 2023 (GLOBE NEWSWIRE) — SkyQuest projects that the GCC steam condensate piping market will attain a value of USD 233.5 million by 2030, with a CAGR of 4.5% over the forecast period (2023-2030). Steam condensate piping offers versatility as it comes in various sizes and materials making it suitable for diverse industrial processes. In addition, the rise in global energy demands owing to the population growth has increased the...

Continue reading

Pharvaris Announces $70 Million Private Placement Financing

ZUG, Switzerland, June 20, 2023 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company focused on the development and commercialization of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin-B2-receptor-mediated indications, today announced that it has entered into a subscription agreement relating to the offer and sale of an aggregate of 6,951,340 ordinary shares of the Company, par value €0.12 per share (the “Ordinary Shares”), in a private placement (the “Offering”) to a group of institutional investors, led by General Atlantic and venBio Partners with participation from Bain Capital Life Sciences, Foresite Capital, and Venrock Healthcare Capital Partners, at an offering price of $10.07 per share, for gross proceeds of approximately $70 million before...

Continue reading

Team, Inc. Announces Successful Closing of Refinancing Transactions

Simplifies Capital Structure and Extends Maturities SUGAR LAND, Texas, June 20, 2023 (GLOBE NEWSWIRE) — Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global, leading provider of specialty industrial services offering clients access to a full suite of conventional, specialized, and proprietary mechanical, heat-treating, and inspection services, today announced the successful closing of a series of previously announced refinancing transactions (the “Transactions”) that raised $87.4 million of new funding (approximately $82 million following deductions for transaction related fees and expenses and original issue discounts) and consisting of the following:A new $57.5 million, 12% senior secured first lien term loan provided by funds managed by Corre Partners Management, LLC (“Corre”) that matures in December 2026, and is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.